Brandi Riddle, chief financial officer at Strive Health, discussed the role technology and predictive analytics will play in changing kidney care in the future.
Transcript:
How does technology play a role in new payment models to change kidney care going forward?
Riddle: Technology is really, really exciting. I think first you have to think about what it could mean to a clinician to be able to predict something about their patient. What if you're able to understand what the risk trajectory is for one of your CKD patients because you've been able to take all of the claims data or you've been able to take various health care partners, and merge that into a single platform and look at kind of this proactive and comprehensive insight on these patients? You can actually understand who might develop kidney disease, who would benefit from early intervention, or who is at risk for further complications, if in fact you aren't able to change the course of their health care journey. You can do those things with predictive analytics, and technological innovation. I think additionally, it helps you target efforts on where to spend your time how to mitigate those high costs. And additionally, what programs should you then as a provider start participating in? So those things are really important, and they don't take away the clinical touch—kidney disease is a very complex disease—and it requires that high [touch] care and very significant engagement. But think about how much better you can do that, and how you can inform your clinical decision making with technology.
Overcoming Employment Barriers for Lasting Social Impact: Freedom House 2.0 and Pathways to Work
April 16th 2024To help celebrate and recognize National Minority Health Month, we are bringing you a special month-long podcast series with our Strategic Alliance Partner, UPMC Health Plan. Welcome to our second episode, in which we learn all about Freedom House 2.0 and the Pathways to Work program.
Listen
Dr Michael Farwell on FDG PET/CT Imaging to Predict Immunotherapy Response in Advanced Melanoma
April 15th 2024Michael Farwell, MD, associate professor of radiology at the Hospital of the University of Pennsylvania, provides insights into a study on the benefits of using 18F-fluorodeoxyglucose (FDG) PET/CT imaging to detect metabolic tumor changes in skin cancer.
Read More
Making Giant Strides in Maternity Health Through Baby Steps
April 9th 2024To help celebrate and recognize National Minority Health Month, we are kicking off a special month-long podcast series with our strategic alliance partner, UPMC Health Plan. Welcome to our first episode, which is all about the Baby Steps Maternity Program and its mission to support women throughout every step of their pregnancy journey.
Listen
FDA Approves Vadadustat for Anemia in Patients With CKD Undergoing Dialysis
March 28th 2024The FDA approved vadadustat (Vafseo), an oral medication, to treat anemia in adult patients with chronic kidney disease (CKD) on dialysis for at least 3 months. This fills a need for a new treatment option as anemia is common in these patients and can significantly impact their quality of life.
Read More
Increasing Lp(a) Awareness for Better Cardiovascular Health: Dr Mary McGowan
March 24th 2024For Lp(a) Awareness Day, Mary McGowan, MD, FNLA, chief medical officer of the Family Heart Foundation, highlights how most people with elevated Lp(a) are completely unaware that they have this increased risk and calls for increased testing.
Read More